ArticleBlood2020
Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria.
Christoph R Kimmich et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this papertrialcites it